Pharmacometrics

Results: 77



#Item
41CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER:  021246Orig1s045 and 021087Orig1s062

CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 021246Orig1s045 and 021087Orig1s062

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2013-04-08 10:07:49
42Advisory Committee for Pharmaceutical Science

Advisory Committee for Pharmaceutical Science

Add to Reading List

Source URL: www.fda.gov

Language: English
43MEMORANDUM  DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCH

MEMORANDUM DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCH

Add to Reading List

Source URL: www.fda.gov

Language: English
44Clinical Pharmacology and Biopharmaceutics Summary _______________________________________________________________________ NDAs: [removed]Serial # SE8-018 Sponsor: GlaxoSmithKline.

Clinical Pharmacology and Biopharmaceutics Summary _______________________________________________________________________ NDAs: [removed]Serial # SE8-018 Sponsor: GlaxoSmithKline.

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2004-09-14 08:01:32
45Final Draft Review  Pharmacometrics Review NDA: DRUG NAME: DOSAGE STRENGTH:

Final Draft Review Pharmacometrics Review NDA: DRUG NAME: DOSAGE STRENGTH:

Add to Reading List

Source URL: www.fda.gov

Language: English
46Quantitative and Systems Pharmacology in the Post-genomic Era: New Approaches to Discovering Drugs and Understanding Therapeutic

Quantitative and Systems Pharmacology in the Post-genomic Era: New Approaches to Discovering Drugs and Understanding Therapeutic

Add to Reading List

Source URL: www.nigms.nih.gov

Language: English - Date: 2013-09-17 17:32:52
47020838_Candesartan_Clinpharm_BPCA

020838_Candesartan_Clinpharm_BPCA

Add to Reading List

Source URL: www.fda.gov

Language: English
48Best starting dose meeting the criteria is 0.75 ?g/kg/min.

Best starting dose meeting the criteria is 0.75 ?g/kg/min.

Add to Reading List

Source URL: www.fda.gov

Language: English
49Curriculum Vitae: Michael Neely

Curriculum Vitae: Michael Neely

Add to Reading List

Source URL: www.fda.gov

Language: English
50CHAPTER 1  Pharmacometrics: Impacting Drug Development and Pharmacotherapy  INTRODUCTION

CHAPTER 1 Pharmacometrics: Impacting Drug Development and Pharmacotherapy INTRODUCTION

Add to Reading List

Source URL: media.wiley.com

Language: English - Date: 2007-10-05 23:12:38